PYC pyc therapeutics limited

Ann: Investor Presentation - October 2017, page-3

  1. 5,482 Posts.
    lightbulb Created with Sketch. 705
    If im not mistaken it seems to state they are about to recommence a trial for Janssens.
    P17 i think under Janssens

    Planning further in
    vivo tests with
    scaffolds targeting
    intracellular targets

    This may be the new dr Hayes influence? Maybe close to an announcement.

    Funny no mention of data packs or blood bourne cancer. Seems we are now closer to breast cancer? Just trying to keep track. The general interest in the platform does seem to be growing.

    This is going to be very interesting to see if the new guys can close deals now.
    Last edited by andrewk65: 09/10/17
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.30
Change
0.000(0.00%)
Mkt cap ! $755.3M
Open High Low Value Volume
$1.29 $1.31 $1.28 $11.03M 8.523M

Buyers (Bids)

No. Vol. Price($)
3 9192 $1.28
 

Sellers (Offers)

Price($) Vol. No.
$1.30 6719 1
View Market Depth
Last trade - 16.10pm 01/07/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.